Search
Neumora Therapeutics Inc
NMRAAdd to Watchlist
1.610USD
-0.040-2.42%
Close 07-31 16:00（ET）Quotes delayed by 15 min
298.31MMarket Cap
LossP/E TTM
NMRA Financials
See Neumora Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Neumora Therapeutics Inc Earnings Date
Latest Release
May 7, 2026
EPS / Forecast
-0.30/-0.31
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-1.45
5.20%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Neumora Therapeutics Inc?
According to Neumora Therapeutics Inc's FY2025 earnings report, its current assets were 190.54M, with a year-on-year change of -39.33.
What are the total assets of Neumora Therapeutics Inc?
According to Neumora Therapeutics Inc's FY2025 earnings report, its total assets of Neumora Therapeutics Inc were 191.05M, with a year-on-year change of -39.73.
What are the total liabilities of Neumora Therapeutics Inc?
According to Neumora Therapeutics Inc's FY2025 earnings report, its total liabilities of Neumora Therapeutics Inc were 87.18M, with a year-on-year change of 191.48.
What is the total equity of Neumora Therapeutics Inc?
According to Neumora Therapeutics Inc's FY2025 earnings report, its total equity of Neumora Therapeutics Inc was 103.87M, with a year-on-year change of -63.82.
What is the net operating income of Neumora Therapeutics Inc?
According to Neumora Therapeutics Inc's FY2025 earnings report, its net operating income of Neumora Therapeutics Inc was -236.16M, with a year-on-year change of 10.36.
What is the net investment of Neumora Therapeutics Inc?
According to Neumora Therapeutics Inc's FY2025 earnings report, its net investment of Neumora Therapeutics Inc was 168.52M, with a year-on-year change of 338.84.
What is the net financing of Neumora Therapeutics Inc?
According to Neumora Therapeutics Inc's FY2025 earnings report, its net financing of Neumora Therapeutics Inc was 77.09M, with a year-on-year change of 256.84.
What is the Earnings Per Share (EPS) of Neumora Therapeutics Inc?
According to Neumora Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.45, with a year-on-year change of 5.20.
What is the net income of Neumora Therapeutics Inc?
According to Neumora Therapeutics Inc's FY2025 earnings report, its net income was -236.93M, with a year-on-year change of 2.81.
What is the Return on Equity (ROE) of Neumora Therapeutics Inc?
According to Neumora Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -121.21, with a year-on-year change of -87.98.
What is the Return on Assets (ROA) of Neumora Therapeutics Inc?
According to Neumora Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -93.28, with a year-on-year change of -55.56.
What is the operating profit of Neumora Therapeutics Inc?
According to Neumora Therapeutics Inc's FY2025 earnings report, its operating profit was -236.16M, with a year-on-year change of 10.36.